Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 5
1986 3
1987 5
1988 15
1989 60
1990 72
1991 128
1992 235
1993 207
1994 301
1995 290
1996 315
1997 344
1998 376
1999 337
2000 419
2001 375
2002 382
2003 453
2004 461
2005 454
2006 465
2007 509
2008 473
2009 468
2010 464
2011 481
2012 552
2013 440
2014 552
2015 502
2016 498
2017 550
2018 551
2019 543
2020 676
2021 729
2022 694
2023 656
2024 273

Text availability

Article attribute

Article type

Publication date

Search Results

13,980 results

Results by year

Filters applied: . Clear all
Page 1
Antiphospholipid syndrome.
Sammaritano LR. Sammaritano LR. Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101463. doi: 10.1016/j.berh.2019.101463. Epub 2019 Dec 19. Best Pract Res Clin Rheumatol. 2020. PMID: 31866276 Review.
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial, venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or pregnancy morbidity in the setting of documented persistent antiphospholipid antib
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial, venous, or small vessel thrombosis and
Antiphospholipid syndrome.
Petri M. Petri M. Transl Res. 2020 Nov;225:70-81. doi: 10.1016/j.trsl.2020.04.006. Epub 2020 May 12. Transl Res. 2020. PMID: 32413497 Free PMC article. Review.
Antiphospholipid syndrome is one of the more common acquired causes of hypercoagulability. Its major presentations are thrombotic (arterial, venous, or microvascular) and pregnancy morbidity (miscarriages, late intrauterine fetal demise, and severe pre-eclampsia). C
Antiphospholipid syndrome is one of the more common acquired causes of hypercoagulability. Its major presentations are thrombo
Antiphospholipid syndrome.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Ruiz-Irastorza G, et al. Lancet. 2010 Oct 30;376(9751):1498-509. doi: 10.1016/S0140-6736(10)60709-X. Epub 2010 Sep 6. Lancet. 2010. PMID: 20822807 Review.
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency. ...Complement activation might have a central pathogenetic role. Of the differ …
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for p …
Managing antiphospholipid syndrome in pregnancy.
Schreiber K, Hunt BJ. Schreiber K, et al. Thromb Res. 2019 Sep;181 Suppl 1:S41-S46. doi: 10.1016/S0049-3848(19)30366-4. Thromb Res. 2019. PMID: 31477227 Review.
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence of antiphospholipid antibodies (aPL). ...
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence of antiphospholipid antibodies (
Diagnosis and management of catastrophic antiphospholipid syndrome.
Carmi O, Berla M, Shoenfeld Y, Levy Y. Carmi O, et al. Expert Rev Hematol. 2017 Apr;10(4):365-374. doi: 10.1080/17474086.2017.1300522. Epub 2017 Mar 13. Expert Rev Hematol. 2017. PMID: 28277850 Review.
Catastrophic antiphospholipid syndrome (CAPS) is a rare, life-threatening disease. In 1992, Asherson defined it as a widespread coagulopathy related to the antiphospholipid antibodies (aPL). ...To obtain the information used in this review, scientific databas …
Catastrophic antiphospholipid syndrome (CAPS) is a rare, life-threatening disease. In 1992, Asherson defined it as a widesprea …
Antiphospholipid Syndrome and Kidney Involvement.
De Simone E, Sciascia S, Fenoglio R, Oddone V, Barreca A, Roccatello D. De Simone E, et al. Kidney Blood Press Res. 2023;48(1):666-677. doi: 10.1159/000529229. Epub 2023 Sep 21. Kidney Blood Press Res. 2023. PMID: 37734329 Free article. Review.
BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the development of autoantibodies and the impairment of the coagulation system. Knowledge about this syndrome is increasing over time, but kidney involvement, especially APS …
BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the development of autoantibodies and th …
Antiphospholipid syndrome.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2018 Jan 11;4:17104. doi: 10.1038/nrdp.2017.104. Nat Rev Dis Primers. 2018. PMID: 29321639 Review. No abstract available.
Antiphospholipid syndrome in cardiovascular disease and cancer.
Pessach I, Kyriakou E, Kalampokas E, Kalampokas T, Bitsani A, Kotsianidis I. Pessach I, et al. Eur J Haematol. 2023 Dec;111(6):834-843. doi: 10.1111/ejh.14096. Epub 2023 Sep 4. Eur J Haematol. 2023. PMID: 37667555 Review.
Antiphospholipid syndrome is an autoimmune disorder which is characterized by the presence of heterogeneous antiphospholipid antibodies. There is an evidence on antiphospholipid (aPL) antibodies related to thromboembolic events in cancer patients. ...
Antiphospholipid syndrome is an autoimmune disorder which is characterized by the presence of heterogeneous antiphospholipi
13,980 results
You have reached the last available page of results. Please see the User Guide for more information.